{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:13:45Z","timestamp":1790097225802,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Innovation Project of Guangxi Graduate Education","award":["YCBZ2024142"],"award-info":[{"award-number":["YCBZ2024142"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U22A20374"],"award-info":[{"award-number":["U22A20374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Shanghai","award":["24ZR1414000"],"award-info":[{"award-number":["24ZR1414000"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202131"],"award-info":[{"award-number":["GKE-ZZ202131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hepatocellular carcinoma (HCC) remains a global health burden, with disproportionately high mortality in China\u2019s Guangxi region, where endemic\n                      <jats:italic>Clonorchis sinensis<\/jats:italic>\n                      (\n                      <jats:italic>C.\u00a0sinensis<\/jats:italic>\n                      ) infection coincides with elevated HCC incidence. Preliminary single-cell sequencing revealed marked overexpression of cluster of differentiation 24 (CD24) in HCC tissues, suggesting its potential pathological role. This study aims to elucidate the oncogenic mechanisms of\n                      <jats:italic>C.\u00a0sinensis<\/jats:italic>\n                      excretory-secretory products (CsESPs) and their link to CD24-mediated HCC progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We employed an integrated clinical and experimental approach. First, clinical cohort analysis assessed CD24 expression in\n                      <jats:italic>C.\u00a0sinensis<\/jats:italic>\n                      -associated HCC cases. Multiplatform bioinformatics validation (GEPIA\/UALCAN\/TIMER) evaluated CD24\u2019s prognostic significance and immune microenvironment modulation. Functional studies (quantitative polymerase chain reaction (qPCR), Western\u00a0blotting, CCK-8 assays, flow cytometry) examined CsESPs\u2019 effects on CD24 expression, cell proliferation, and apoptosis. Mechanistic investigations (chromatin immunoprecipitation, dual-luciferase reporter assays) identified E2F1-mediated transcriptional activation of CD24. siRNA-mediated CD24 knockdown validated its role in CsESPs-driven oncogenesis. Additionally, the expression of immune checkpoint (CTLA-4, LAG-3) was assessed in the co-cultures of peripheral blood mononuclear cells (PBMCs)\u2013HCC cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Clinical cohort analysis confirmed significant CD24 upregulation in HCC, particularly in\n                      <jats:italic>C.\u00a0sinensis<\/jats:italic>\n                      -infected cases. Bioinformatic analyses linked high CD24 expression to poor prognosis and immune microenvironment alterations. Functional assays demonstrated that CsESPs enhance CD24 expression, promoting proliferation and inhibiting apoptosis. Mechanistically, E2F1 directly binds to CD24 promoter, driving its transcription upon CsESPs exposure. CD24 silencing reversed CsESPs-induced oncogenic effects. Furthermore, CsESPs upregulated immune checkpoints (CTLA-4, LAG-3) in the co-cultures of PBMC\u2013HCC cells, an effect reversed by CD24 knockdown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings establish a novel parasitic carcinogenesis paradigm wherein\n                      <jats:italic>C.\u00a0sinensis<\/jats:italic>\n                      promotes HCC development through E2F1-mediated transcriptional activation of CD24, simultaneously identifying prognostic biomarkers and therapeutic targets while suggesting combinatory immunotherapy strategies for parasite-associated HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-06979-6","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T12:16:35Z","timestamp":1755605795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications"],"prefix":"10.1186","volume":"18","author":[{"given":"Wen-Min","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Ru","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Zhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"6979_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"6979_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent."},{"key":"6979_CR3","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"6979_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41:1037\u201348.","journal-title":"Cancer Commun (Lond)"},{"key":"6979_CR5","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, Zhou Z, Yin P, Zhou M. National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8:e943\u201355.\u00a0","journal-title":"Lancet Public Health."},{"key":"6979_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","volume":"387","author":"M Zhou","year":"2016","unstructured":"Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387:251\u201372.","journal-title":"Lancet"},{"key":"6979_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3969\/j.issn.1674-5671.2021.02.05","volume":"13","author":"Q Li","year":"2021","unstructured":"Li Q, Cao J, Rong M, Zhou Z, Yu H, Ge L, et al. Analysis of incidence and mortality of liver cancer in cancer registration areas in Guangxi, 2010\u20132016. J Chin J Oncol Prev Treat. 2021;13:138\u201343.","journal-title":"J Chin J Oncol Prev Treat"},{"key":"6979_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41182-021-00297-0","volume":"49","author":"ZH Jiang","year":"2021","unstructured":"Jiang ZH, Wan XL, Lv GL, Zhang WW, Lin Y, Tang WQ, et al. High prevalence of Clonorchis sinensis infection in Guangxi, Southern China. Trop Med Health. 2021;49:6.","journal-title":"Trop Med Health"},{"key":"6979_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-016-0166-1","volume":"5","author":"ZL Tang","year":"2016","unstructured":"Tang ZL, Huang Y, Yu XB. Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control. Infect Dis Poverty. 2016;5:71.","journal-title":"Infect Dis Poverty"},{"key":"6979_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biology10060533","author":"MNA Hatta","year":"2021","unstructured":"Hatta MNA, Mohamad Hanif EA, Chin SF, Neoh HM. Pathogens and carcinogenesis: a review. Biology (Basel). 2021;10(6).\u00a0","journal-title":"Biology (Basel)"},{"key":"6979_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3347\/kjp.2019.57.4.379","volume":"57","author":"JH Pak","year":"2019","unstructured":"Pak JH, Lee JY, Jeon BY, Dai F, Yoo WG, Hong SJ. Cytokine production in cholangiocarcinoma cells in response to Clonorchis sinensis excretory-secretory products and their putative protein components. Korean J Parasitol. 2019;57:379\u201387.","journal-title":"Korean J Parasitol"},{"key":"6979_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105309","volume":"203","author":"BK Na","year":"2020","unstructured":"Na BK, Pak JH, Hong SJ. Clonorchis sinensis and clonorchiasis. Acta Trop. 2020;203:105309.","journal-title":"Acta Trop"},{"key":"6979_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, EI Ghissassi F, et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol. 2009;10:321\u20132.","journal-title":"Lancet Oncol"},{"key":"6979_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011906","volume":"18","author":"Q Lin","year":"2024","unstructured":"Lin Q, Tang Z, Qin Y, Deng X, Wei C, Liu F, et al. Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis. PLoS Negl Trop Dis. 2024;18:e0011906.","journal-title":"PLoS Negl Trop Dis"},{"key":"6979_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011012","volume":"17","author":"YK Li","year":"2023","unstructured":"Li YK, Zhao JF, Yang CL, Zhan GH, Zhang J, Qin SD, et al. Effects of Clonorchis sinensis combined with hepatitis B virus infection on the prognosis of patients with hepatocellular carcinoma following hepatectomy. PLoS Negl Trop Dis. 2023;17:e0011012.","journal-title":"PLoS Negl Trop Dis"},{"key":"6979_CR16","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1007\/s00436-022-07699-x","volume":"121","author":"Y Qi","year":"2022","unstructured":"Qi Y, Hu J, Liang J, Hu X, Ma N, Xiang B. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat. Parasitol Res. 2022;121:3403\u201315.","journal-title":"Parasitol Res"},{"key":"6979_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102206118","author":"C Yan","year":"2021","unstructured":"Yan C, Zhou QY, Wu J, Xu N, Du Y, Li J, et al. Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries. Proc Natl Acad Sci U S A. 2021;118(46).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6979_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13071-017-2179-4","volume":"10","author":"C Wang","year":"2017","unstructured":"Wang C, Lei H, Tian Y, Shang M, Wu Y, Li Y, et al. Clonorchis sinensis granulin: identification, immunolocalization, and function in promoting the metastasis of cholangiocarcinoma and hepatocellular carcinoma. Parasit Vectors. 2017;10:262.\u00a0","journal-title":"Parasit Vectors"},{"key":"6979_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.734750","volume":"11","author":"C Wang","year":"2021","unstructured":"Wang C, He Q, Yin Y, Wu Y, Li X. Clonorchis sinensis granulin promotes malignant transformation of hepatocyte through EGFR-mediated RAS\/MAPK\/ERK and PI3K\/Akt signaling pathways. Front Cell Infect Microbiol. 2021;11:734750.","journal-title":"Front Cell Infect Microbiol"},{"key":"6979_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13071-023-05765-6","volume":"16","author":"Q He","year":"2023","unstructured":"He Q, Pan X, Yin Y, Xu A, Yi X, Wu Y, Li X. Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3 phosphorylation and the MEK\/ERK pathway. Parasit Vectors. 2023;16:139.\u00a0","journal-title":"Parasit Vectors"},{"key":"6979_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572:392\u20136.","journal-title":"Nature"},{"key":"6979_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02421","volume":"9","author":"FFK Mensah","year":"2018","unstructured":"Mensah FFK, Armstrong CW, Reddy V, Bansal AS, Berkovitz S, Leandro MJ, et al. CD24 expression and B cell maturation shows a novel link with energy metabolism: potential implications for patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Front Immunol. 2018;9:2421.","journal-title":"Front Immunol"},{"key":"6979_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/B:HIJO.0000032357.16261.c5","volume":"35","author":"G Kristiansen","year":"2004","unstructured":"Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol. 2004;35:255\u201362.","journal-title":"J Mol Histol"},{"key":"6979_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0753-3322(05)80076-9","volume":"59","author":"SC Lim","year":"2005","unstructured":"Lim SC. CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother. 2005;59:351\u20134.\u00a0","journal-title":"Biomed Pharmacother"},{"key":"6979_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ajpath.2020.12.014","volume":"191","author":"Y Tolkach","year":"2021","unstructured":"Tolkach Y, Zarbl R, Bauer S, Ritter M, Ellinger J, Hauser S, et al. DNA promoter methylation and ERG regulate the expression of CD24 in prostate cancer. Am J Pathol. 2021;191:618\u201330.","journal-title":"Am J Pathol"},{"key":"6979_CR26","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1634\/stemcells.2007-0101","volume":"25","author":"SA Ochsner","year":"2007","unstructured":"Ochsner SA, Strick-Marchand H, Qiu Q, Venable S, Dean A, Wilde M, et al. Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers. Stem Cells. 2007;25:2476\u201387.","journal-title":"Stem Cells"},{"key":"6979_CR27","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1158\/1078-0432.CCR-09-0151","volume":"15","author":"XR Yang","year":"2009","unstructured":"Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res. 2009;15:5518\u201327.","journal-title":"Clin Cancer Res"},{"key":"6979_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.675207","author":"JI Chang","year":"2021","unstructured":"Chang JI, Lee K, Kim D, Yang JI, Park JK, Choi K, et al. Clinical characteristics of Clonorchis sinensis-associated cholangiocarcinoma: a large-scale, single-center study. Front Med (Lausanne). 2021;8:675207.","journal-title":"Front Med (Lausanne)"},{"key":"6979_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.16250\/j.32.1374.2017108","volume":"29","author":"C Ying-Dan","year":"2017","unstructured":"Ying-Dan C, Ting-Jun Z, Long-Qi X, Bin Z, Yan-Hong X, Chang-Hai Z. Interpretation of diagnostic criteria for clonorchiasis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017;29:538\u201340.\u00a0","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi."},{"key":"6979_CR30","doi-asserted-by":"crossref","unstructured":"Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18036.","DOI":"10.1038\/nrdp.2018.36"},{"key":"6979_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8070361","author":"UK Sah","year":"2023","unstructured":"Sah UK, Sah AK, Ansari M, Chaudhary P, Gupta S, Kumar P, Sah JP. HCV co-infection and its genotypic distribution in HIV-infected patients in Nepalese population. Trop Med Infect Dis. 2023;8(7).","journal-title":"Trop Med Infect Dis."},{"key":"6979_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/cr.2013.11","volume":"23","author":"J Zhou","year":"2013","unstructured":"Zhou J, Tan SH, Nicolas V, Bauvy C, Yang ND, Zhang J, et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Cell Res. 2013;23:508\u201323.","journal-title":"Cell Res"},{"key":"6979_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110426","author":"H Wei","year":"2025","unstructured":"Wei H, Chen Y, Qin Z, Wang H, Liu Y, Song T, et al. Artesunate demonstrates neuroprotective effect through activation of lysosomal function and inhibition of cGAS-STING pathway. Neuropharmacology. 2025:110426.","journal-title":"Neuropharmacology"},{"key":"6979_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42:301\u201310.","journal-title":"Acta Pharmacol Sin"},{"key":"6979_CR35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.27593","volume":"61","author":"GD Lu","year":"2015","unstructured":"Lu GD, Ang YH, Zhou J, Tamilarasi J, Yan B, Lim YC, et al, Hooi SC. CCAAT\/enhancer binding protein alpha predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma. Hepatology. 2015;61:965\u201378.\u00a0","journal-title":"Hepatology"},{"key":"6979_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155089","volume":"121","author":"XY Li","year":"2023","unstructured":"Li XY, Cui X, Xie CQ, Wu Y, Song T, He JD, et al. Andrographolide causes p53-independent HCC cell death through p62 accumulation and impaired DNA damage repair. Phytomedicine. 2023;121:155089.","journal-title":"Phytomedicine"},{"key":"6979_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12672-024-01284-7","volume":"15","author":"C Zhao","year":"2024","unstructured":"Zhao C, Huang Y, Zhang H, Lui H. CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers. Discov Oncol. 2024;15:399.\u00a0","journal-title":"Discov Oncol"},{"key":"6979_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/trstmh\/trv100","volume":"110","author":"DH Lai","year":"2016","unstructured":"Lai DH, Hong XK, Su BX, Liang C, Hide G, Zhang X, et al. Current status of Clonorchis sinensis and clonorchiasis in China. Trans R Soc Trop Med Hyg. 2016;110:21\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6979_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012638","volume":"18","author":"C Wei","year":"2024","unstructured":"Wei C, Chen J, Yu Q, Qin Y, Huang T, Liu F, et al. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression via enhancing angiogenesis. PLoS Negl Trop Dis. 2024;18:e0012638.","journal-title":"PLoS Negl Trop Dis"},{"key":"6979_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1280358","volume":"13","author":"Q Li","year":"2023","unstructured":"Li Q, Li X, Kan S, Zhu TJ, Li C, Du XY, et al. Clonorchis sinensis calcium-binding protein Cs16 causes acute hepatic injury possibly by reprogramming the metabolic pathway of bone marrow-derived monocytes. Front Cell Infect Microbiol. 2023;13:1280358.","journal-title":"Front Cell Infect Microbiol"},{"key":"6979_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002606","volume":"7","author":"X Chen","year":"2013","unstructured":"Chen X, Li S, He L, Wang X, Liang P, Chen W, et al. Molecular characterization of severin from Clonorchis sinensis excretory\/secretory products and its potential anti-apoptotic role in hepatocarcinoma PLC cells. PLoS Negl Trop Dis. 2013;7:e2606.","journal-title":"PLoS Negl Trop Dis"},{"key":"6979_CR42","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1158\/2159-8290.CD-20-1114","volume":"11","author":"AC Mandigo","year":"2021","unstructured":"Mandigo AC, Yuan W, Xu K, Gallagher P, Pang A, Guan YF, et al. RB\/E2F1 as a master regulator of cancer cell metabolism in advanced disease. Cancer Discov. 2021;11:2334\u201353.","journal-title":"Cancer Discov"},{"key":"6979_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/cdd.2014.146","volume":"22","author":"A Kumari","year":"2015","unstructured":"Kumari A, Iwasaki T, Pyndiah S, Cassimere EK, Palani CD, Sakamuro D. Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation. Cell Death Differ. 2015;22:311\u201322.","journal-title":"Cell Death Differ"},{"key":"6979_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03112-4","volume":"23","author":"LL Cao","year":"2023","unstructured":"Cao LL, Wu YK, Lin TX, Lin M, Chen YJ, Wang LQ, et al. CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling. Cancer Cell Int. 2023;23:286.","journal-title":"Cancer Cell Int"},{"key":"6979_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409724122","volume":"122","author":"L Sun","year":"2025","unstructured":"Sun L, Hu P, Yang H, Ren J, Hu R, Wu S, et al. ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA. Proc Natl Acad Sci U S A. 2025;122:e2409724122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6979_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167117","volume":"1870","author":"X He","year":"2024","unstructured":"He X, Zhang Y, Fang Q, Sun Y, Zheng X, Fu Y, et al. Unraveling the role of CD24 in hepatocellular carcinoma: involvement of inactivated Hippo signaling and SOX4-mediated regulation. Biochimica et Biophysica Acta (BBA). 2024;1870:167117.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"6979_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006074","volume":"11","author":"M Shi","year":"2017","unstructured":"Shi M, Zhou L, Zhao L, Shang M, He T, Tang Z, et al. Csseverin inhibits apoptosis through mitochondria-mediated pathways triggered by Ca2 + dyshomeostasis in hepatocarcinoma PLC cells. PLoS Negl Trop Dis. 2017;11:e0006074.","journal-title":"PLoS Negl Trop Dis"},{"key":"6979_CR48","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00436-017-5409-y","volume":"116","author":"M Shang","year":"2017","unstructured":"Shang M, Xie Z, Tang Z, He L, Wang X, Wang C, et al. Expression of Clonorchis sinensis GIIIsPLA(2) protein in baculovirus-infected insect cells and its overexpression facilitating epithelial-mesenchymal transition in Huh7 cells via AKT pathway. Parasitol Res. 2017;116:1307\u201316.","journal-title":"Parasitol Res"},{"key":"6979_CR49","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-21-2390","volume":"28","author":"LP Andrews","year":"2022","unstructured":"Andrews LP, Cillo AR, Karapetyan L, Kirkwood JM, Workman CJ, Vignali DAA. Molecular pathways and mechanisms of LAG3 in cancer therapy. Clin Cancer Res. 2022;28:5030\u20139.","journal-title":"Clin Cancer Res"},{"key":"6979_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan O, Giles JR, McDonald S, Manne S, Ngiow SF, Patel KP,et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature. 2019;571:211\u20138.","journal-title":"Nature"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06979-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:59:13Z","timestamp":1757476753000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06979-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6979"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06979-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6378057\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}